Great release todayI personally love the fact that the management team is nimble and identified a potential use for IP that they currently have on the shelf. The addition of Dr. Boulware is testament to the fact that there is substance to this, he is currently one of the Dr. working with the WH for Covid19.
This alone could be a company maker. I initially invested because I love the psychedelic space and see huge upside for RVV in that market, coupled with the existing cannabis IP.
RVV now has three exciting verticals that definitley should attract investors attention. I am willing to stay long through the global and market turmoil to see where this can go.